by Brittany Phillips, University of North Carolina at Chapel Hill School of Medicine Credit: Unsplash/CC0 Public Domain A four-year clinical trial led by Edwin Kim, MD, at the UNC School of Medicine, has found that an increased dosage of a unique type of peanut allergy immunotherapy continues to show promise for children. A four-year phase 2 clinical trial demonstrated...
